Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia

References

• 1 Liong M, Lu J, Kovochich M et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5), 889–896 (2008).
  Medline CASGoogle Scholar
• 2 Kim J, Piao Y, Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 38(2), 372–390 (2009).
  Medline CASGoogle Scholar
• 3 De M, Ghosh PS, Rotello VM. Applications of nanoparticles in biology. Adv. Mater. 20(22), 4225–4241 (2008).
  CASGoogle Scholar
• 4 Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14(14), 2161–2175 (2004).
  CASGoogle Scholar
• 5 Yoo D, Lee J-H, Shin T-H, Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res. 44(10), 863–874 (2011).
  Medline CASGoogle Scholar
• 6 Colombo M, Carregal-Romero S, Casula MF et al. Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 41(11), 4306–4334 (2012).
  Medline CASGoogle Scholar
• 7 Dufort S, Bianchi A, Henry M et al. Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization. Small 11(2), 215–221 (2015).
  Medline CASGoogle Scholar
• 8 Laurent S, Forge D, Port M et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108(6), 2064–2110 (2008).
  Medline CASGoogle Scholar
• 9 Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18), 3995–4021 (2005).
  Medline CASGoogle Scholar
• 10 Maier-Hauff K, Rothe R, Scholz R et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 81(1), 53–60 (2007).
  Medline CASGoogle Scholar
• 11 Maier-Hauff K, Ulrich F, Nestler D et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 103(2), 317–324 (2011).
  MedlineGoogle Scholar
• 12 Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia 24(6), 467–474 (2008).
  Medline CASGoogle Scholar
• 13 Deatsch AE, Evans BA. Heating efficiency in magnetic nanoparticle hyperthermia. J. Magn. Magn. Mater. 354(0), 163–172 (2014).
  CASGoogle Scholar
• 14 Kolosnjaj-Tabi J, Di Corato R, Lartigue L et al. Heat-generating iron oxide nanocubes: subtle “destructurators” of the tumoral microenvironment. ACS Nano 8(5), 4268–4283 (2014).
  Medline CASGoogle Scholar
• 15 Lee J-H, Jang J-T, Choi J-S et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol. 6(7), 418–422 (2011).
  Medline CASGoogle Scholar
• 16 Jaszberenyi Z, Sour A, Toth E, Benmelouka M, Merbach AE. Fine-tuning water exchange on GdIII poly(amino carboxylates) by modulation of steric crowding. Dalton Trans. (16), 2713–2719 (2005).
  MedlineGoogle Scholar
• 17 Duan H, Kuang M, Wang X, Wang YA, Mao H, Nie S. Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: new insights into spin disorder and proton relaxivity. J. Phys. Chem. C 112(22), 8127–8131 (2008).
  CASGoogle Scholar
• 18 Villaraza AJL, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem. Rev. 110(5), 2921–2959 (2010).
  Medline CASGoogle Scholar
• 19 Joshi HM, Lin YP, Aslam M et al. Effects of shape and size of cobalt ferrite nanostructures on their MRI contrast and thermal activation. J. Phys. Chem. C 113(41), 17761–17767 (2009).
  CASGoogle Scholar
• 20 Lee J-H, Huh Y-M, Jun Y-W et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13(1), 95–99 (2006).
  MedlineGoogle Scholar
• 21 Smolensky ED, Park H-YE, Zhou Y, Marjanska M, Botta M, Pierre V. Scaling laws at the nano size: the effect of particle size and shape on the magnetism and relaxivity of iron oxide nanoparticle contrast agents. J. Mater. Chem. B 1(22), 2818–2828 (2013).
  Medline CASGoogle Scholar
• 22 Zeng L, Ren W, Zheng J, Cui P, Wu A. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging. Phys. Chem. Chem. Phys. 14(8), 2631–2636 (2012).
  Medline CASGoogle Scholar
• 23 Kim BH, Lee N, Kim H et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 133(32), 12624–12631 (2011).
  Medline CASGoogle Scholar
• 24 Pöselt E, Kloust H, Tromsdorf U et al. Relaxivity optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T₂-weighted spin–echo imaging. ACS Nano 6(2), 1619–1624 (2012).
  Medline CASGoogle Scholar
• 25 Daou TJ, Pourroy G, Bégin-Colin S et al. Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chem. Mater. 18(18), 4399–4404 (2006).
  CASGoogle Scholar
• 26 Wang W, Pacheco V, Krause H-J et al. Size and compositional effects on contrast efficiency of functionalized superparamagnetic nanoparticles at ultralow and ultrahigh magnetic fields. J. Phys. Chem. C 116(33), 17880–17884 (2012).
  CASGoogle Scholar
• 27 Yoon T-J, Lee H, Shao H, Weissleder R. Highly magnetic core–shell nanoparticles with a unique magnetization mechanism. Angew. Chem. Int. Ed. Engl. 50(20), 4663–4666 (2011).
  Medline CASGoogle Scholar
• 28 Cheong S, Ferguson P, Feindel KW et al. Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging. Angew. Chem. Int. Ed. Engl. 50(18), 4206–4209 (2011).
  Medline CASGoogle Scholar
• 29 Lacroix L-M, Frey Huls N, Ho D, Sun X, Cheng K, Sun S. Stable single-crystalline body centered cubic Fe nanoparticles. Nano Lett. 11(4), 1641–1645 (2011).
  Medline CASGoogle Scholar
• 30 Khurshid H, Hadjipanayis CG, Chen H et al. Core/shell structured iron/iron-oxide nanoparticles as excellent MRI contrast enhancement agents. J. Magn. Magn. Mater. 331, 17–20 (2013).
  CASGoogle Scholar
• 31 De Montferrand C, Hu L, Milosevic I et al. Iron oxide nanoparticles with sizes, shapes and compositions resulting in different magnetization signatures as potential labels for multiparametric detection. Acta Biomater. 9(4), 6150–6157 (2013).
  Medline CASGoogle Scholar
• 32 Lee N, Choi Y, Lee Y et al. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r2 relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett. 12(6), 3127–3131 (2012).
  Medline CASGoogle Scholar
• 33 Zhao Z, Zhou Z, Bao J et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. Nat. Commun. 4, 2266 (2013).
  MedlineGoogle Scholar
• 34 Sathya A, Guardia P, Brescia R et al. CoxFe3–xO4 nanocubes for theranostic applications: effect of cobalt content and particle size. Chem. Mater. 28(6), 1769–1780 (2016).
  CASGoogle Scholar
• 35 Saha I, Chaffee KE, Duanmu C et al. pH-Sensitive MR responses induced by dendron-functionalized SPIONs. J. Phys. Chem. C 117(4), 1893–1903 (2012).
  Google Scholar
• 36 Paquet C, De Haan HW, Leek DM et al. Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T2 relaxation. ACS Nano 5(4), 3104–3112 (2011).
  Medline CASGoogle Scholar
• 37 Roca AG, Veintemillas-Verdaguer S, Port M, Robic C, Serna CJ, Morales MP. Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. J. Phys. Chem. B 113(19), 7033–7039 (2009).
  Medline CASGoogle Scholar
• 38 Lartigue L, Hugounenq P, Alloyeau D et al. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. ACS Nano 6(12), 10935–10949 (2012).
  Medline CASGoogle Scholar
• 39 Kostopoulou A, Velu SKP, Thangavel K et al. Colloidal assemblies of oriented maghemite nanocrystals and their NMR relaxometric properties. Dalton Trans. 43(22), 8395–8404 (2014).
  Medline CASGoogle Scholar
• 40 Laurent S, Bridot J-L, Elst LV, Muller RN. Magnetic iron oxide nanoparticles for biomedical applications. Future Med. Chem. 2(3), 427–449 (2010).
  Medline CASGoogle Scholar
• 41 Roch A, Gossuin Y, Muller RN, Gillis P. Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J. Magn. Magn. Mater. 293(1), 532–539 (2005).
  CASGoogle Scholar
• 42 Li W, Tutton S, Vu AT et al. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J. Magn. Reson. Imag. 21(1), 46–52 (2005).
  MedlineGoogle Scholar
• 43 Shen T, Weissleder R, Papisov M, Bogdanov A, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 29(5), 599–604 (1993).
  Medline CASGoogle Scholar
• 44 Jun Y-W, Huh Y-M, Choi J-S et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc. 127(16), 5732–5733 (2005).
  Medline CASGoogle Scholar
• 45 Tong S, Hou S, Zheng Z, Zhou J, Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 10(11), 4607–4613 (2010).
  Medline CASGoogle Scholar
• 46 Basly B, Popa G, Fleutot S et al. Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents. Dalton Trans. 42(6), 2146–2157 (2012).
  Google Scholar
• 47 Jang J-T, Nah H, Lee J-H, Moon SH, Kim MG, Cheon J. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew. Chem. Int. Ed. Engl. 48(7), 1234–1238 (2009).
  Medline CASGoogle Scholar
• 48 Huang J, Bu L, Xie J et al. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 4(12), 7151–7160 (2010).
  Medline CASGoogle Scholar
• 49 Lee N, Kim H, Choi SH et al. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets. Proc. Natl Acad. Sci. USA 108(7), 2662–2667 (2011).
  Medline CASGoogle Scholar
• 50 Walter A, Garofalo A, Parat A et al. Validation of a dendron concept to tune colloidal stability, MRI relaxivity and bioelimination of functional nanoparticles. J. Mater. Chem. B 3(8), 1484–1494 (2015).
  CASGoogle Scholar
• 51 Laconte LEW, Nitin N, Zurkiya O et al. Coating thickness of magnetic iron oxide nanoparticles affects R₂ relaxivity. J. Magn. Reson. Imag. 26(6), 1634–1641 (2007).
  MedlineGoogle Scholar
• 52 Pinho SLC, Laurent S, Rocha JO et al. Relaxometric studies of γ-Fe₂O₃@SiO₂ core shell nanoparticles: when the coating matters. J. Phys. Chem. C 116(3), 2285 (2012).
  CASGoogle Scholar
• 53 Laurent S, Nicotra C, Gossuin Y et al. Influence of the length of the coating molecules on the nuclear magnetic relaxivity of superparamagnetic colloids. Phys. Status Solidi 1(12), 3644–3650 (2004).
  CASGoogle Scholar
• 54 Walter A, Billotey C, Garofalo A et al. Mastering the shape and composition of dendronized iron oxide nanoparticles to tailor magnetic resonance imaging and hyperthermia. Chem. Mater. 26(18), 5252–5264 (2014).
  CASGoogle Scholar
• 55 Bordonali L, Kalaivani T, Sabareesh KPV et al. NMR-D study of the local spin dynamics and magnetic anisotropy in different nearly monodispersed ferrite nanoparticles. J. Phys. 25(6), 066008 (2013).
  CASGoogle Scholar
• 56 Xiao N, Gu W, Wang H, Deng Y, Shi X, Ye L. T₁–T₂ dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles. J. Colloid Interface Sci. 417, 159–165 (2014).
  Medline CASGoogle Scholar
• 57 Cui X, Belo S, Krüger D et al. Aluminium hydroxide stabilised MnFe₂O₄ and Fe₃O₄ nanoparticles as dual-modality contrasts agent for MRI and PET imaging. Biomaterials 35(22), 5840–5846 (2014).
  Medline CASGoogle Scholar
• 58 Yang H, Zhuang Y, Sun Y et al. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 32(20), 4584–4593 (2011).
  Medline CASGoogle Scholar
• 59 Yang M, Gao L, Liu K et al. Characterization of Fe₃O₄/SiO₂/Gd₂O(CO₃)₂ core/shell/shell nanoparticles as T₁ and T₂ dual mode MRI contrast agent. Talanta 131, 661–665 (2015).
  Medline CASGoogle Scholar
• 60 Borges M, Yu S, Laromaine A et al. Dual T1/T2 MRI contrast agent based on hybrid SPION@coordination polymer nanoparticles. RSC Adv. 5(105), 86779–86783 (2015).
  CASGoogle Scholar
• 61 Kumar CSSR, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev. 63(9), 789–808 (2011).
  Medline CASGoogle Scholar
• 62 Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann. Surg. 146(4), 596–606 (1957).
  Medline CASGoogle Scholar
• 63 Laurent S, Dutz S, Häfeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci. 166(1–2), 8–23 (2011).
  Medline CASGoogle Scholar
• 64 Périgo EA, Hemery G, Sandre O et al. Fundamentals and advances in magnetic hyperthermia. Appl. Phys. Rev. 2(4), 041302 (2015).
  Google Scholar
• 65 Rosensweig RE. Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252(0), 370–374 (2002).
  CASGoogle Scholar
• 66 Kallumadil M, Tada M, Nakagawa T, Abe M, Southern P, Pankhurst QA. Suitability of commercial colloids for magnetic hyperthermia. J. Magn. Magn. Mater. 321(10), 1509–1513 (2009).
  CASGoogle Scholar
• 67 Cullity BD, Graham CD. Introduction To Magnetic Materials. John Wiley & Sons (2011).
  Google Scholar
• 68 Dormann JL, Bessais L, Fiorani D. A dynamic study of small interacting particles: superparamagnetic model and spin-glass laws. J. Phys. C 21(10), 2015 (1988).
  Google Scholar
• 69 El-Hilo M, O'grady K, Chantrell RW. The ordering temperature in fine particle systems. J. Magn. Magn. Mater. 117(1–2), 21–28 (1992).
  Google Scholar
• 70 Shtrikman S, Wohlfarth EP. The theory of the Vogel–Fulcher law of spin glasses. Phys. Lett. A 85(8), 467–470 (1981).
  Google Scholar
• 71 Gunnar G, Rudolf H, Matthias Z, Silvio D, Stefan N, Werner W. The effect of field parameters, nanoparticle properties and immobilization on the specific heating power in magnetic particle hyperthermia. J. Phys. 18(38), S2935 (2006).
  Google Scholar
• 72 Brezovich IA. Low frequency hyperthermia: capacitive and ferromagnetic thermoseed methods. Med. Phys. Monogr. 16, 82–111 (1988).
  Google Scholar
• 73 Fortin J-P, Wilhelm C, Servais J, Ménager C, Bacri J-C, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129(9), 2628–2635 (2007).
  Medline CASGoogle Scholar
• 74 De la Presa P, Luengo Y, Multigner M et al. Study of heating efficiency as a function of concentration, size, and applied field in γ-Fe₂O₃ nanoparticles. J. Phys. Chem. C 116(48), 25602–25610 (2012).
  CASGoogle Scholar
• 75 Liu XL, Fan HM, Yi JB et al. Optimization of surface coating on Fe₃O₄ nanoparticles for high performance magnetic hyperthermia agents. J. Mater. Chem. 22(17), 8235–8244 (2012).
  CASGoogle Scholar
• 76 Jordan A, Rheinländer T, Waldöfner N, Scholz R. Increase of the specific absorption rate (SAR) by magnetic fractionation of magnetic fluids. J. Nanopart. Res. 5(5), 597–600 (2003).
  CASGoogle Scholar
• 77 Patsula V, Moskvin M, Dutz S, Horák D. Size-dependent magnetic properties of iron oxide nanoparticles. J. Phys. Chem. Solids 88, 24–30 (2016).
  CASGoogle Scholar
• 78 Guardia P, Di Corato R, Lartigue L et al. Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano 6(4), 3080–3091 (2012).
  Medline CASGoogle Scholar
• 79 Kossatz S, Ludwig R, Dähring H et al. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharm. Res. 31(12), 3274–3288 (2014).
  Medline CASGoogle Scholar
• 80 Brusentsov NA, Gogosov VV, Brusentsova TN et al. Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro. J. Magn. Magn. Mater. 225(1–2), 113–117 (2001).
  CASGoogle Scholar
• 81 Gazeau F, Lévy M, Wilhelm C. Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine 3(6), 831–844 (2008).
  CASGoogle Scholar
• 82 Hergt R, Hiergeist R, Zeisberger M et al. Magnetic properties of bacterial magnetosomes as potential diagnostic and therapeutic tools. J. Magn. Magn. Mater. 293(1), 80–86 (2005).
  CASGoogle Scholar
• 83 Baaziz W, Pichon BP, Lefevre C et al. High exchange bias in Fe_3−δO₄@CoO core shell nanoparticles synthesized by a one-pot seed-mediated growth method. J. Phys. Chem. C 117(21), 11436–11443 (2013).
  CASGoogle Scholar
• 84 Baaziz W, Pichon BP, Liu Y et al. Tuning of synthesis conditions by thermal decomposition toward core–shell CoxFe₁–xO@CoyFe₃–yO₄ and CoFe₂O₄ nanoparticles with spherical and cubic shapes. Chem. Mater. 26(17), 5063–5073 (2014).
  CASGoogle Scholar
• 85 Iglesias Ò, Labarta A, Batlle X. Exchange bias phenomenology and models of core/shell nanoparticles. J. Nanosci. Nanotechnol. 8(6), 2761–2780 (2008).
  Medline CASGoogle Scholar
• 86 Martinez-Boubeta C, Simeonidis K, Makridis A et al. Learning from nature to improve the heat generation of iron-oxide nanoparticles for magnetic hyperthermia applications. Sci. Rep. 3, 1652 (2013).
  MedlineGoogle Scholar
• 87 Gonzalez-Fernandez MA, Torres TE, Andrés-Vergés M et al. Magnetic nanoparticles for power absorption: optimizing size, shape and magnetic properties. J. Solid State Chem. 182(10), 2779–2784 (2009).
  CASGoogle Scholar
• 88 Habib AH, Ondeck CL, Chaudhary P, Bockstaller MR, Mchenry ME. Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy. J. Appl. Phys. 103(7), 07A307 (2008).
  Google Scholar
• 89 Mehdaoui B, Tan RP, Meffre A et al. Increase of magnetic hyperthermia efficiency due to dipolar interactions in low-anisotropy magnetic nanoparticles: theoretical and experimental results. Phys. Rev. B 87(17), 174419 (2013).
  Google Scholar
• 90 Hugounenq P, Levy M, Alloyeau D et al. Iron oxide monocrystalline nanoflowers for highly efficient magnetic hyperthermia. J. Phys. Chem. C 116(29), 15702–15712 (2012).
  CASGoogle Scholar
• 91 Blanco-Andujar C, Ortega D, Southern P, Pankhurst QA, Thanh NTK. High performance multi-core iron oxide nanoparticles for magnetic hyperthermia: microwave synthesis, and the role of core-to-core interactions. Nanoscale 7(5), 1768–1775 (2015).
  Medline CASGoogle Scholar
• 92 Dennis CL, Jackson AJ, Borchers JA et al. Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology 20(39), 395103 (2009).
  Medline CASGoogle Scholar
• 93 Novakova AA, Smirnov EV, Gendler TS. Magnetic anisotropy in Fe₃O₄–PVA nanocomposites as a result of Fe₃O₄-nanoparticles chains formation. J. Magn. Magn. Mater. 300(1), e354–e358 (2006).
  CASGoogle Scholar
• 94 Serantes D, Simeonidis K, Angelakeris M et al. Multiplying magnetic hyperthermia response by nanoparticle assembling. J. Phys. Chem. C 118(11), 5927–5934 (2014).
  CASGoogle Scholar
• 95 Alphandéry E, Faure S, Seksek O, Guyot F, Chebbi I. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano 5(8), 6279–6296 (2011).
  Medline CASGoogle Scholar
• 96 Noh S-H, Na W, Jang J-T et al. Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis. Nano Lett. 12(7), 3716–3721 (2012).
  Medline CASGoogle Scholar
• 97 Di Corato R, Espinosa A, Lartigue L et al. Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs. Biomaterials 35(24), 6400–6411 (2014).
  Medline CASGoogle Scholar
• 98 Etheridge ML, Hurley KR, Zhang J et al. Accounting for biological aggregation in heating and imaging of magnetic nanoparticles. Technology 2(3), 214–228 (2014).
  MedlineGoogle Scholar
• 99 Creixell M, Bohórquez AC, Torres-Lugo M, Rinaldi C. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano 5(9), 7124–7129 (2011).
  Medline CASGoogle Scholar
• 100 Yoo D, Jeong H, Noh S-H, Lee J-H, Cheon J. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. Angew. Chem. Int. Ed. Engl. 52(49), 13047–13051 (2013).
  Medline CASGoogle Scholar
• 101 Wang L, Yan Y, Wang M et al. An integrated nanoplatform for theranostics via multifunctional core-shell ferrite nanocubes. J. Mater. Chem. B 4(10), 1908–1914 (2016).
  CASGoogle Scholar
• 102 Yunok O, Nohyun L, Hyun Wook K, Junghwan O. In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe₂O₄. Nanotechnology 27(11), 115101 (2016).
  MedlineGoogle Scholar
• 103 Connord V, Clerc P, Hallali N et al. Real-time analysis of magnetic hyperthermia experiments on living cells under a confocal microscope. Small 11(20), 2437–2445 (2015).
  Medline CASGoogle Scholar
• 104 Blanco-Andujar C, Ortega D, Southern P, Nesbitt SA, Thanh NTK, Pankhurst QA. Real-time tracking of delayed-onset cellular apoptosis induced by intracellular magnetic hyperthermia. Nanomedicine 11(2), 121–136 (2015).
  Google Scholar
• 105 Shah BP, Pasquale N, De G, Tan T, Ma J, Lee K-B. Core–shell nanoparticle-based peptide therapeutics and combined hyperthermia for enhanced cancer cell apoptosis. ACS Nano 8(9), 9379–9387 (2014).
  Medline CASGoogle Scholar
• 106 Balasubramanian S, Girija AR, Nagaoka Y et al. Curcumin and 5-Fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int. J. Nanomedicine 9, 437–459 (2014).
  MedlineGoogle Scholar
• 107 Sadhukha T, Wiedmann TS, Panyam J. Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials 35(27), 7860–7869 (2014).
  Medline CASGoogle Scholar
• 108 Asín L, Ibarra MR, Tres A, Goya GF. Controlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentration. Pharm. Res. 29(5), 1319–1327 (2012).
  Medline CASGoogle Scholar
• 109 Sanchez C, El Hajj Diab D, Connord V et al. Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death. ACS Nano 8(2), 1350–1363 (2014).
  Medline CASGoogle Scholar
• 110 Hildebrandt B, Wust P, Ahlers O et al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43(1), 33–56 (2002).
  MedlineGoogle Scholar
• 111 Otte J. Hyperthermia in cancer therapy. Eur. J. Pediatr. 147(6), 560–569 (1988).
  Medline CASGoogle Scholar
• 112 Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7(11), 653–664 (2010).
  Medline CASGoogle Scholar
• 113 Gao W, Zheng Y, Wang R et al. A smart, phase transitional and injectable DOX/PLGA-Fe implant for magnetic-hyperthermia-induced synergistic tumor eradication. Acta Biomater. 29, 298–306 (2016).
  Medline CASGoogle Scholar
• 114 Matsuoka F, Shinkai M, Honda H, Kubo T, Sugita T, Kobayashi T. Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma. Biomagn. Res. Technol. 2, 3–3 (2004).
  MedlineGoogle Scholar
• 115 Hilger I, Kaiser WA. Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine 7(9), 1443–1459 (2012).
  CASGoogle Scholar
• 116 Moroz P, Jones SK, Gray BN. Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model. J. Surg. Oncol. 80(3), 149–156 (2002).
  MedlineGoogle Scholar
• 117 Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int. J. Nanomedicine 8, 2521–2532 (2013).
  MedlineGoogle Scholar
• 118 Dähring H, Grandke J, Teichgräber U, Hilger I. Improved hyperthermia treatment of tumors under consideration of magnetic nanoparticle distribution using micro-CT imaging. Mol. Imag. Biol. 17(6), 763–769 (2015).
  Medline CASGoogle Scholar
• 119 Shetake NG, Kumar A, Gaikwad S et al. Magnetic nanoparticle-mediated hyperthermia therapy induces tumour growth inhibition by apoptosis and Hsp90/AKT modulation. Int. J. Hyperthermia 31(8), 909–919 (2015).
  Medline CASGoogle Scholar
• 120 Hayashi K, Nakamura M, Miki H et al. Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release. Theranostics 4(8), 834–844 (2014).
  MedlineGoogle Scholar
• 121 Espinosa A, Bugnet M, Radtke G et al. Can magneto-plasmonic nanohybrids efficiently combine photothermia with magnetic hyperthermia? Nanoscale 7(45), 18872–18877 (2015).
  Medline CASGoogle Scholar
• 122 Hayashi K, Nakamura M, Sakamoto W et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 3(6), 366–376 (2013).
  Medline CASGoogle Scholar
• 123 Basel MT, Balivada S, Wang H et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int. J. Nanomedicine 7, 297–306 (2012).
  Medline CASGoogle Scholar
• 124 Denardo SJ, Denardo GL, Natarajan A et al. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice. J. Nucl. Med. 48(3), 437–444 (2007).
  Medline CASGoogle Scholar
• 125 Xie J, Zhang Y, Yan C et al. High-performance PEGylated Mn–Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics. Biomaterials 35(33), 9126–9136 (2014).
  Medline CASGoogle Scholar